K230842

Substantially Equivalent

SignalHF (IM008)

Applicant: Implicity, Inc.
Product code: QNL
Advisory panel: Cardiovascular
Date received: 2023-03-28
Decision date: 2023-10-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cambridge, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.